Please Wait
Applying Filters...
menu
    • menu
    Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

    Data Compilation
    #PharmaFlow

    Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

    Stock Recap
    #PipelineProspector

    Menu

    Elitox

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 730Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    29/11/2025 Lunan Pharmaceutical
    China
    		 Otran Korea Co., Ltd. 20230623-211-J-1342(A) Migritol 2025-01-13 Lunan New Time Bio-Tech Co., Ltd. China No.2, North Outer Ring Road, Feixian, County, Shandong Province, China
    29/11/2025 Lunan Pharmaceutical
    China
    		 Daewon Pharmaceutical Co., Ltd. 20230623-211-J-1342 Migritol 2023-06-23 Lunan New Time Bio-Tech Co., Ltd. China No.2, North Outer Ring Road, Feixian, County, Shandong Province